This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.
Platelets are little blood cells that assist your body stop bleeding by forming clots. When a blood artery in your body is injured, it sends signals to your platelets. Platelets rush to the damaged area and form a plug (clot) to stop the bleeding. Adhesion is the process of a substance spreading across the surface of a damaged blood vessel to halt bleeding. This is because platelets develop sticky tentacles that help them stick (adhere) to one another when they reach the injury site. Chemical signals are also sent out to recruit additional platelets. Aggregation is the process through which more platelets build up on the clot.
Coagulation, also known as clotting, is the transformation of blood from a liquid to a gel, resulting in the formation of a blood clot. It could lead to haemostasis, or the halt of blood loss from a damaged vessel, and then repair. Coagulation is caused by platelet activation, adhesion, and aggregation, as well as fibrin deposition and maturation. After a damage to the endothelium lining a blood artery, coagulation begins nearly immediately. When blood is exposed to the subendothelial space, two processes occur: platelet modifications and the exposure of subendothelial tissue factor to plasma factor VII, which results in the creation of cross-linked fibrin.
Coagulation is the process of forming a blood clot, which is necessary for haemostasis. The body's physiological response to injured blood arteries is haemostasis, which lowers, minimises, and eventually stops bleeding. The creation of a blood clot is characterised by a series of processes known as the coagulation process. Clotting factors are proteins that start processes that trigger other clotting factors. This happens through two routes that come together downstream to establish a single pathway that facilitates haemostasis.
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clinical management of sickle cell disease
Lambros K Bourantas, Larnaca General Hospital, Cyprus
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Blood transfusion challenges for one stop perioperative clinic care
Hanadi M Aljedani, King Abdullah Medical City, Saudi Arabia